Rb targets histone H3 methylation and HP1 to promoters
Søren Jensby Nielsen(Wellcome/Cancer Research UK Gurdon Institute), Robert Schneider(Wellcome Trust), Uta‐Maria Bauer(Wellcome Trust), Andrew J. Bannister(Wellcome Trust), Ashby J. Morrison(Baylor College of Medicine), Dónal O’Carroll(Research Institute of Molecular Pathology), Ron Firestein(Stanford Medicine), Michael L. Cleary(Stanford Medicine), Thomas Jenuwein(Research Institute of Molecular Pathology), Rafael E. Herrera(Baylor College of Medicine), Tony Kouzarides(Wellcome Trust)
Cited by 884